US FDA should be required to provide 510(k) decision summaries for devices - a missed opportunity by lawmakers
This article was originally published in SRA
Executive Summary
Jeffrey Shapiro explains why medical device companies would benefit from regular and detailed Food and Drug Administration 510(k) decision summaries.